Tax, this is pharma - Deloitte
Pharmaceutical companies entering into toll manufacturing arrangements 2 on a cross-border basis may be particularly exposed to a set of challenges. In a number of Middle Easters countries, foreign entities are prohibited from trading or owning goods in said country unless they are duly licensed and registered with the competent authorities.